Showing results (121-130 of 148) with videos related to
Sort By:
Pageof 15
Hepatology Research : the Official Journal of the Japan Society of Hepatology|September 18, 2025
Serum Growth Differentiation Factor 15 Can Be a Novel Biomarker to Predict the Prognosis of Patients With Hepatitis C Virus Cirrhosis After Virus EliminationYuta Myojin, Hayato Hikita, Yuki Tahata, et al.Journal of Gastroenterology|October 1, 2020
Sofosbuvir plus velpatasvir treatment for hepatitis C virus in patients with decompensated cirrhosis: a Japanese real-world multicenter studyYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.Biomarker Research|September 24, 2025
Long non-coding RNA PWRN4 associated with post-SVR hepatocellular carcinoma: a genome-wide association studyGoki Suda, Masaya Sugiyama, Hayato Hikita, et al.Journal of Gastroenterology|June 1, 2017
Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in JapanGoki Suda, Norihiro Furusyo, Hidenori Toyoda, et al.Journal of Gastroenterology|June 20, 2025
Pretreatment serum angiopoietin-2 predicts prognosis and liver functional reserve after successful HCV eradication with sofosbuvir and velpatasvir in patients with HCV-related decompensated cirrhosisNaoki Kawagishi, Goki Suda, Yuki Tahata, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|July 29, 2025
Human Leukocyte Antigen Genotypes Affect Hepatitis B Virus Mutations Associated With Hepatocellular CarcinomaMasaya Sugiyama, Nao Nishida, Seik-Soon Khor, et al.JHEP Reports : Innovation in Hepatology|April 17, 2025
Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCCRisako Kohya, Goki Suda, Masatsugu Ohara, et al.Journal of Gastroenterology|January 21, 2022
Liver-related events after direct-acting antiviral therapy in patients with hepatitis C virus-associated cirrhosisYuki Tahata, Hayato Hikita, Satoshi Mochida, et al.Journal of Gastroenterology|March 7, 2025
Current management and future perspectives of covert hepatic encephalopathy in Japan: a nationwide surveyTakao Miwa, Mio Tsuruoka, Hajime Ueda, et al.Hepatology Research : the Official Journal of the Japan Society of Hepatology|August 12, 2022
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinibMargherita Rimini, Wonseok Kang, Valentina Burgio, et al.Pageof 15